The US Commerce Department said Friday that it's letting ZTE, which makes smartphones and telecommunications equipment, resume buying components from American companies.
The Commerce Department reached a deal with ZTE last month, agreeing to lift its ban after the company paid a $1 billion fine and put $400 million in an escrow account. The fine was paid in late June, and Ross said Friday that the $400 million had arrived at a US bank.
ZTE also agreed to bring in an American monitoring team and overhaul its top management as part of the deal. It recently named a new CEO and replaced its entire board to meet US demands.
The Commerce Department said Friday that these measures were the "harshest penalties and strictest compliance measures ever imposed in such a case."
"While we lifted the ban on ZTE, the Department will remain vigilant as we closely monitor ZTE's actions to ensure compliance with all US laws and regulations," Commerce Secretary Wilbur Ross said in a statement.
Best Value Stocks To Watch Right Now: W.R. Grace & Co.(GRA)
W. R. Grace & Co. is engaged in the production and sale of specialty chemicals and specialty materials on a global basis through three operating segments: Grace Catalysts Technologies, which includes catalysts and related products and technologies used in refining, petrochemical and other chemical manufacturing applications; Grace Materials Technologies, which includes packaging technologies and engineered materials used in consumer, industrial, and pharmaceutical applications; and Grace Construction Products, which includes specialty construction chemicals and specialty building materials used in commercial, infrastructure and residential construction. We entered the specialty chemicals industry in 1954, when we acquired both the Dewey and Almy Chemical Company and the Davison Chemical Company. Grace is the successor to a company that began in 1854 and originally became a public company in 1953. Advisors' Opinion:
- [By Joseph Griffin]
Tyers Asset Management LLC bought a new stake in W. R. Grace & Co (NYSE:GRA) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 2,464 shares of the specialty chemicals company’s stock, valued at approximately $181,000.
- [By Ethan Ryder]
These are some of the media stories that may have impacted Accern Sentiment Analysis’s analysis:
Get W. R. Grace & Co alerts: W.R. Grace & Co.: Grace Announces Release Date for Second Quarter 2018 Results (twst.com) W. R. Grace & Co (GRA) Expected to Earn Q2 2018 Earnings of $0.90 Per Share (americanbankingnews.com) W. R. Grace & Co (GRA) to Post Q3 2018 Earnings of $0.96 Per Share, Jefferies Financial Group Forecasts (americanbankingnews.com) Venator Materials and Three Additional Specialty Chemicals Stocks on Our Research Desk's Radar (finance.yahoo.com)W. R. Grace & Co traded up $0.71, reaching $74.39, on Friday, according to Marketbeat. The stock had a trading volume of 378,610 shares, compared to its average volume of 720,257. W. R. Grace & Co has a fifty-two week low of $58.48 and a fifty-two week high of $77.37. The company has a quick ratio of 1.01, a current ratio of 1.56 and a debt-to-equity ratio of 6.23. The stock has a market cap of $4.96 billion, a PE ratio of 21.88, a PEG ratio of 1.58 and a beta of 1.19.
- [By Max Byerly]
Chemours (NYSE: CC) and W. R. Grace & Co (NYSE:GRA) are both mid-cap basic materials companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.
- [By Joseph Griffin]
W. R. Grace and (NYSE: GRA) and DSM (OTCMKTS:RDSMY) are both basic materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, dividends, risk and institutional ownership.
Best Value Stocks To Watch Right Now: Equus Total Return, Inc.(EQS)
Equus Total Return, Inc. (the Fund), incorporated on August 16, 1991, is a closed-end management investment company. The Fund's investment objective is to maximize the total return to the Company's stockholders in the form of current investment income and long-term capital gains by investing in the debt and equity securities of small and middle market capitalization companies that are generally not publicly traded at the time of its investment. The Company seeks to invest primarily in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts and recapitalizations of existing businesses or special situations. The Company's income-producing investments consist principally of debt securities including subordinate debt, debt convertible into common or preferred stock, or debt combined with warrants and common and preferred stock.
The investment operations of the Fund consist principally of the basic activities, which include investment selection, due diligence, structuring investments, and providing management assistance and monitoring of investments. The Fund's investment opportunities come from management, members of the Board, other private equity investors, direct approaches from prospective portfolio companies and referrals from investment banks, business brokers, commercial, regional and local banks, attorneys, accountants and other members of the financial community. Once a potential investment is identified, the Company undertakes a due diligence review using information provided by the prospective portfolio companies and publicly available information. The Company negotiates investments in private transactions directly with the owner or issuer of the securities acquired. The Fund seeks to provide guidance and management assistance with respect to such matters as capital structure, acquisitions, budgets, profit goals, corporate strategy, portfolio management and potential sale of the Company or other exit strategies.
! The Fund makes follow-on investments in portfolio companies from cash on hand or borrows all or a portion of the funds required. If it is unable to make follow-on investments due to lack of available capital, the portfolio company in need of the investment may be negatively impacted and its equity interest in the portfolio company may be diluted if outside equity capital is required.
Advisors' Opinion:- [By Joseph Griffin]
Media coverage about Equus Total Return (NYSE:EQS) has trended positive this week, according to Accern Sentiment. Accern identifies positive and negative news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Equus Total Return earned a coverage optimism score of 0.39 on Accern’s scale. Accern also assigned media headlines about the investment management company an impact score of 51.7885599154335 out of 100, indicating that recent news coverage is somewhat likely to have an effect on the company’s share price in the near future.
- [By Anders Melin]
Taking that a step further, you can run searches on the Equity Screening (EQS) function using the new pay metrics or data on say-on-pay, which refers to shareholders’ right to vote on management remuneration. To see Russell 1000 companies with the lowest support on pay, for example, go to {EQS <GO>}. In the Add Criteria field, enter RIY and click on the Russell 1000 Index match. Next, enter Say on Pay, click on the Say on Pay Support Level item, and press <GO>. Click on the See Results | WATC button for a list of companies in the benchmark that you can sort by the percentage of shareholders supporting management on pay.
Best Value Stocks To Watch Right Now: Abeona Therapeutics Inc.(ABEO)
About Abeona: Abeona Therapeutics, Inc. develops and delivers gene therapy and plasma-based products for severe and life-threatening rare diseases. Abeona's lead programs are AB0-101 (AAV9 NAGLU) and ABO-102 (scAAV9 SGSH), adeno-associated virus (AAV)-based gene therapies for Sanfilippo syndrome (MPS IIIB and IIIA) in collaboration with patient advocate groups, researchers and clinicians, anticipated to commence clinical trials in 2015. We are also developing ABO-201 (scAAV9 CLN3) gene therapy for juvenile Batten disease (JBD); and ABO-301 (AAV LK19 FANCC) for Fanconi anemia (FA) disorder using a novel CRISPR/Cas9-based gene editing approach to gene therapy program for rare blood diseases. In addition, we are also developing rare plasma protein therapies including SDF Alpha(TM) (alpha-1 protease inhibitor) for inherited COPD using our proprietary SDF(TM) (Salt Diafiltration) ethanol-free process. For more information, visit www.abeonatherapeutics.com. Advisors' Opinion:
- [By Shane Hupp]
Abeona Therapeutics Inc (NASDAQ:ABEO) shares traded up 9.2% during mid-day trading on Friday . The company traded as high as $8.14 and last traded at $8.10. 657,079 shares were traded during mid-day trading, an increase of 65% from the average session volume of 399,426 shares. The stock had previously closed at $7.42.
- [By Logan Wallace]
Abeona Therapeutics (NASDAQ:ABEO) was given a $36.00 price target by analysts at Cantor Fitzgerald. The firm currently has a buy rating on the stock.
- [By Ethan Ryder]
Shares of Abeona Therapeutics Inc (NASDAQ:ABEO) have been assigned a consensus rating of “Buy” from the thirteen ratings firms that are covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and ten have given a buy recommendation to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $29.44.
- [By Stephan Byrd]
Abeona Therapeutics (NASDAQ:ABEO) was downgraded by equities research analysts at ValuEngine from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Thursday.
Best Value Stocks To Watch Right Now: Charter Financial Corp.(CHFN)
Charter Financial Corporation operates as the holding company for CharterBank that provides various banking services to individuals and businesses in Georgia and Alabama. Its deposit products include demand, NOW, and money market accounts; savings deposits; time deposits; checking accounts; and certificates of deposit. The company's loan products comprise commercial real estate loans; one- to four-family residential mortgage loans; construction and development loans; commercial business loans; and consumer loans, such as home equity loans, lines of credit, auto loans, and second mortgage loans. It operates through 16 branch offices located in West Point, LaGrange, Newnan, Carrollton, Bremen, Covington, and Peachtree City, Georgia; and Auburn, Opelika, and Valley, Alabama, as well as through a loan production office located in Norcross, Georgia. The company was founded in 1954 and is based in West Point, Georgia. Charter Financial Corporation operates as a subsidiary of Fir st Charter, MHC.
Advisors' Opinion:- [By Shane Hupp]
Atlantic Coast Financial (NASDAQ: CHFN) and Charter Financial Corp (Maryland) (NASDAQ:CHFN) are both small-cap finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, risk, dividends, analyst recommendations and institutional ownership.
- [By Stephan Byrd]
Kearny Financial (NASDAQ: CHFN) and Charter Financial Corp (Maryland) (NASDAQ:CHFN) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, earnings, valuation, dividends, institutional ownership and risk.
- [By Shane Hupp]
OMERS ADMINISTRATION Corp purchased a new stake in shares of Charter Financial Corp (Maryland) (NASDAQ:CHFN) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 58,300 shares of the bank’s stock, valued at approximately $1,408,000. OMERS ADMINISTRATION Corp owned approximately 0.38% of Charter Financial Corp (Maryland) as of its most recent SEC filing.
No comments:
Post a Comment